Please assess the completion status of the following clinical trial:

Trial Title: Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Any age, but primarily infants 0-6 months.~* Children with confirmed diagnosis of congenital hyperinsulinism.~Exclusion Criteria:~* Cases in which surgery will not be considered by parents or guardians.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Subjects who had PET and surgery (Type: EXPERIMENTAL): Children diagnosed with hyperinsulinism who have failed other non-surgical interventions and are candidates to be scheduled for surgery for partial pancreatectomy. Eligible children will undergo PET imaging with F-DOPA prior to surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).